IceCure Medical Ltd
ICCM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $65 | $58 | $68 | $61 |
| - Cash | $5 | $5 | $6 | $8 |
| + Debt | $0 | $2 | $0 | $0 |
| Enterprise Value | $60 | $55 | $62 | $54 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 61.9% | -27.6% | -17.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 32.6% | 25% | 30.1% | 47.7% |
| EBITDA | -$4 | -$3 | -$4 | -$4 |
| % Margin | -442.7% | -633% | -492.1% | -507.8% |
| Net Income | -$4 | -$3 | -$4 | -$4 |
| % Margin | -454% | -640.8% | -494.9% | -511.9% |
| EPS Diluted | -0.06 | -0.057 | -0.062 | -0.081 |
| % Growth | -5.4% | 7.9% | 22.8% | – |
| Operating Cash Flow | -$3 | -$3 | -$4 | -$4 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$3 | -$3 | -$4 | -$4 |